Nasopharyngeal carcinoma (NPC) is relatively common in Southeast Asia and Southern China. Because of the nasopharynx’s complex anatomy, tumors often grow adjacent to critical structures such as the brainstem, cranial nerves, Eustachian tube, oral cavity, and pharyngeal mucosa.

Conventional radiotherapy remains the mainstay of treatment, but its limitations are clear. Patients often endure dry mouth, oral ulcers, loose teeth, loss of taste, and other side effects that significantly impact quality of life.

Conventional Radiotherapy: Effective but Costly in Side Effects

-Wide radiation fields – Standard radiotherapy frequently exposes normal tissue around the nasopharynx, increasing complication risks.

-Noticeable side effects – Oral mucosal injury, throat discomfort, difficulty swallowing, and chronic xerostomia are common in NPC patients.

-Challenging recurrences – Once a patient has received full-dose radiotherapy, options for re-irradiation are very limited and high-risk.

The key challenge remains: how to eradicate tumors while preserving surrounding organs and functions.

CyberKnife: A “Sharpshooter” for Nasopharyngeal Cancer

CyberKnife is a robotic stereotactic radiosurgery system that delivers sub-millimeter accuracy (as precise as 0.1 millimeters). For Nasopharyngeal Cancer, it offers targeted tumor control while sparing nearby structures:

-High precision – Focuses radiation directly on the tumor, avoiding unnecessary exposure.

-Fewer side effects – Protects oral cavity, salivary glands, teeth, and pharyngeal tissues to the greatest extent possible.

-Shorter treatment course – Most patients complete therapy in just 1–5 sessions, avoiding prolonged hospital visits..

-Options for recurrence – Provides a viable approach for patients with recurrent disease after surgery or conventional radiotherapy.

A Three-Year Follow-Up: From Nosebleeds to Recovery

Mr. Liu, 44, first noticed blood-streaked nasal discharge, tinnitus, and nasal obstruction in 2018. He was diagnosed with stage III nasopharyngeal carcinoma.

Because of underlying liver cirrhosis, he was unsuitable for aggressive treatment. He underwent standard intensity-modulated radiotherapy (IMRT), supplemented by 5 sessions of CyberKnife boost therapy.

• Early 2019: Follow-up imaging showed significant tumor shrinkage, with no enlarged cervical lymph nodes.

• 2022: Three years post-treatment, there was no evidence of recurrence or metastasis.

His attending physician concluded: “Integrating CyberKnife as a boost in the later phase of radiotherapy not only shortened the overall treatment course but also significantly reduced oral mucosal toxicity, while maintaining excellent tumor control.”

Case source: Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine 

International-Standard Cancer Care in Foshan

“At Foshan Fosun Chancheng Hospital, we take on what others cannot, and do what others will not.” This is the mission of our Precision Oncology Center. The center is among the first in China to launch joint China–U.S. multidisciplinary (MDT) consultations, integrating radiotherapy, medical oncology, targeted therapy, and precision diagnostics to deliver highly individualized care.

Cutting-Edge Technology: CyberKnife M6

- Real-time tumor tracking, sparing oral cavity, salivary glands, and temporal lobes.

- Entirely non-invasive, painless, with each session lasting only minutes.

- High single-dose delivery shortens treatment course and reduces costs.

World-Class Expertise: Specialists and Physicists Working Together

- Dr. Yang Jun – Contributor to international CyberKnife physics quality-control standards.

- Prof. Cui Nianji – Leading radiation oncology expert in Southern China.

- Dr. Wang Baodong – Chair of the Physics Committee, Radiosurgery Society (North America).

This team, supported by physicists and an MDT network, ensures CyberKnife delivers its full clinical potential.

Nasopharyngeal Cancer: Precision That Protects Quality of Life

For tumors located near the skull base and oral cavity, the Chancheng Hospital team emphasizes “precision with protection”. CyberKnife not only controls tumor growth but also safeguards taste, swallowing, and speech functions—allowing patients to live with dignity during and after treatment.

Who Can Benefit from CyberKnife?

- Patients with recurrent NPC after conventional radiotherapy.

- Patients unable to tolerate wide-field radiation or concerned about side effects.

- Tumors near critical structures such as the skull base, temporal lobes, or oral cavity.

- Patients who wish to balance effective treatment with preserved quality of life.

Beyond Cure: Living Well

For patients with nasopharyngeal cancer, treatment is not only about eradicating the tumor but also about preserving the dignity of daily life. CyberKnife offers the chance to control disease while reducing oral and pharyngeal complications, helping patients live more comfortably.

At Foshan Fosun Chancheng Hospital, international expertise and advanced technology come together to provide not just effective treatment—but also confidence and hope.

Precise yet gentle. Quiet yet powerful. CyberKnife is opening new pathways to recovery for patients with nasopharyngeal cancer.